Pierrel Pharma: + 35% in first quarter 2016 sales Orabloc

9 years ago - Published in Finance, Fundamental Analysis

Pierrel Pharma, a subsidiary of Pierrel, announced that Orabloc, its flagship anesthetic, recorded in the first quarter of the year increased sales by 35% compared to the same period of 2015. Considering only the month of March, the product It showed an increase of 42% in sales, reaching a record from 2012 in the North American market. The performance in the first quarter "reinforces the management of Pierrel the idea to accompany towards loftier goals its pharma" division, we read in today's statement.